Related Experiment Videos
Peroxisome proliferator-activated receptor agonists
1Glaxo Wellcome Research and Development NTH-M2134, PO Box 13398, Research Triangle Park, North Carolina, 27709-3398, USA. wilsontm@glaxo.com.
Current Opinion in Chemical Biology
|August 1, 1997
Summary
Peroxisome proliferator-activated receptors (PPARs) are transcription factors activated by ligands. Both synthetic drugs and natural compounds bind PPARs, aiding in the study of these crucial biological molecules.
Area of Science:
- Molecular Biology
- Endocrinology
- Pharmacology
Background:
- Peroxisome proliferator-activated receptors (PPARs) comprise a family of three nuclear receptor proteins.
- These receptors are ligand-activated transcription factors, playing key roles in metabolic regulation.
- PPARs are implicated in various physiological processes, including lipid and glucose homeostasis.
Purpose of the Study:
- To identify and characterize ligands that bind to peroxisome proliferator-activated receptors.
- To explore the utility of identified ligands in understanding PPAR biology.
- To provide a foundation for further research into PPAR-mediated pathways.
Main Methods:
- Identification of synthetic ligands, including fibrate antihyperlipidemic and thiazolidinedione antihyperglycemic drugs.
- Characterization of natural ligands, such as unsaturated fatty acids and eicosanoids.
- Utilizing these ligands as molecular tools to investigate PPAR function.
Main Results:
- Fibrate and thiazolidinedione drugs were confirmed as synthetic PPAR ligands.
- Naturally occurring unsaturated fatty acids and eicosanoids were identified as endogenous PPAR ligands.
- The diverse range of ligands provides powerful means to study PPARs.
Conclusions:
- PPARs are activated by a variety of synthetic and natural ligands.
- These ligands are instrumental in dissecting the complex biology of PPARs.
- Further investigation into ligand-receptor interactions can reveal therapeutic targets.